nach oben

Annals of Hematology

Erschienen in:

08.05.2018 | Letter to the Editor

Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis

verfasst von: Stefano Molica, Diana Giannarelli, Rosanna Mirabelli, Luciano Levato, Tait D. Shanafelt

Erschienen in: Annals of Hematology | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Nur mit Berechtigung zugänglich

International CLL-IPI working group (2016) An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. Lancet Oncol 17(6):779–790CrossRef

Gentile M, Shanafelt TD, Rossi D, Laurenti L, Mauro FR, Molica S, Cutrona G, Uccello G, Campanelli M, Vigna E, Tripepi G, Chaffee KG, Parikh SA, Bossio S, Recchia AG, Innocenti I, Pasquale R, Neri A, Ferrarini M, Gaidano G, Foa R, Morabito F (2016) Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients. Blood 128(16):2093–2095CrossRef

da Cunha-Bang C, Christiansen I, Niemann CU (2016) The CLL-IPI applied in a population-based cohort. Blood 128(17):2181–2183CrossRef

Goede V, Bahlo J, Kutsch N et al (2016) Evaluation of the International prognostic index for chronic lymphocytic leukemia (CLL-IPI) in elderly patients with comorbidities: analysis of the CLL11 study population. Blood 128:4401

Ferrer Lores B, Navarro Cubells B, Serrano Alcala A et al (2016) Prognostic impact of the new CLL-IPI Index in a single center CLL Spanish cohort. Blood 128:2019

Delgado J, Doubek M, Baumann T, Kotaskova J, Molica S, Mozas P, Rivas-Delgado A, Morabito F, Pospisilova S, Montserrat E (2017) Chronic lymphocytic leukemia: a prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI. Am J Hematol 92(4):375–380CrossRef

Rigolin GM, Cavallari M, Quaglia FM, Formigaro L, Lista E, Urso A, Guardalben E, Liberatore C, Faraci D, Saccenti E, Bassi C, Lupini L, Bardi MA, Volta E, Tammiso E, Melandri A, Negrini M, Cavazzini F, Cuneo A (2017) In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI. Blood 129(26):3495–3498CrossRef

Reda G, Cassin R, Fattizzo B, Giannarelli D, Mattiello V, Barcellini W, Cortelezzi A (2017) Chronic lymphocytic leukemia and prognostic models: a bridge between clinical and biological markers. Am J Hematol 92(7):E135–E137CrossRef

Molica S, Shanafelt TD, Giannarelli D, Gentile M, Mirabelli R, Cutrona G, Levato L, di Renzo N, di Raimondo F, Musolino C, Angrilli F, Famà A, Recchia AG, Chaffee KG, Neri A, Kay NE, Ferrarini M, Morabito F (2016) The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: independent validation in a prospective cohort of early stage patients. Am J Hematol 91:1090–1095CrossRef

10.

Soumerai JD, Barrientos JC, Hallek M et al (2016) An evaluation of the chronic lymphocytic leukemia (CLL) international prognostic index as a prognostic tool in patients with relapsed/refractory CLL in idelalisib phase 3 randomized studies. J Clin Oncol 34(15_suppl):7513CrossRef

11.

Brander DM, Rhodes J, Pagel JM et al (2017) Applicability of the chronic lymphocytic leukemia (CLL)-IPI on patients treated with front-line ibrutinib in the real world: the case for new prognostic models. Blood 130:1719

12.

Soumerai JD, Ni A, Darif M et al (2017) A validated risk model for overall survival in relapsed/refractory chronic lymphocytic leukemia applicable to patients treated with novel therapies and standard of care. Blood 130:4303

13.

Molica S, Giannarelli D, Mirabelli R, Levato L, Kay NE, Shanafelt TD (2018) Chronic lymphocytic leukemia international prognostic index (CLL-IPI): a systematic review and meta-analysis. Blood 131(3):365–368CrossRef

Titel: Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis
verfasst von: Stefano Molica
Diana Giannarelli
Rosanna Mirabelli
Luciano Levato
Tait D. Shanafelt
Publikationsdatum: 08.05.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Annals of Hematology / Ausgabe 10/2018
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-018-3350-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

16.04.2024 | Chronische Herzinsuffizienz | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Manche Gestagene können das Risiko für Meningeome erhöhen

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Innere Medizin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2018

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study

Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1

The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study

Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP)

Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia

High chymotrypsin-like activity in the plasma of patients with newly diagnosed multiple myeloma treated with bortezomib is predictive of a better response and longer PFS

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Manche Gestagene können das Risiko für Meningeome erhöhen

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Innere Medizin